Back to Results
First PageMeta Content



Pluristem Issues Letter to Shareholders HAIFA, Israel, February 07, Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today reported financial resu
Add to Reading List

Document Date: 2018-02-07 08:35:32


Open Document

File Size: 517,31 KB

Share Result on Facebook
UPDATE